Cargando…

Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-β story

Detalles Bibliográficos
Autores principales:	Imbimbo, Bruno P., Balducci, Claudia, Ippati, Stefania, Watling, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241406/ https://www.ncbi.nlm.nih.gov/pubmed/35799522 http://dx.doi.org/10.4103/1673-5374.340409

Ejemplares similares

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

Can Anti–β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
por: Osborne, Olivia M., et al.
Publicado: (2023)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

A long story for a short peptide: therapeutic efficacy of a cleavage-specific tau antibody
por: Amadoro, Giuseppina, et al.
Publicado: (2021)

Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023)

Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
por: Balducci, Claudia, et al.
Publicado: (2019)

Extracellular vesicles drive tau spreading in Alzheimer's disease
por: Ruan, Zhi
Publicado: (2021)

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
por: Cai, Yue, et al.
Publicado: (2023)

Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease
por: Kelley, Sara, et al.
Publicado: (2022)

Enrichment of novel Tau isoform with altered biochemical properties in Alzheimer’s disease
por: Ong, Chin-Tong
Publicado: (2023)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

Type 2 Diabetes Mellitus, Platelet Activation and Alzheimer’s Disease: A Possible Connection
por: Carbone, Manuel Glauco, et al.
Publicado: (2022)

TDP-43 and amyloid precursor protein processing: implications for Alzheimer’s disease
por: Hicks, David A.
Publicado: (2020)

Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
por: Ramanan, Vijay K., et al.
Publicado: (2023)

Clearance of amyloid‐beta with bispecific antibody constructs bound to erythrocytes
por: Taylor, Ronald P., et al.
Publicado: (2020)

A crate of Pandora: do amyloids from bacteria promote Alzheimer’s disease?
por: Nguyen, Vu Thu Thuy, et al.
Publicado: (2020)

The tip of the iceberg? The underestimated potential of non-canonical beta-amyloids for Alzheimer’s disease
por: Busch, Lukas, et al.
Publicado: (2023)

Neurofibrillary tangles in Alzheimer's disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics
por: Metaxas, Athanasios, et al.
Publicado: (2016)

Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline
por: Robinson, Stephen R., et al.
Publicado: (2018)

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
por: Fessel, Jeffrey
Publicado: (2022)

Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease
por: Richard, Edo, et al.
Publicado: (2021)

The Love Canal Story Is Not Finished
por: Clapp, Richard
Publicado: (2009)

The danger of stories in global health
por: Harman, Sophie
Publicado: (2020)

Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid
por: King, Michelle E., et al.
Publicado: (2006)

Reminiscences
por: Karen Worth (née Weisskopf)
Publicado: (2002)

Reminiscences
por: Glatstein, Eli
Publicado: (2010)

Reminiscences
por: Thekkepat, Gopinathan
Publicado: (2010)

Reminiscences
por: Bonhorst, C. G. Von
Publicado: (1886)

Reminiscences
por: Packard, Francis R.
Publicado: (1927)

Reminiscences
Publicado: (1886)

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
por: Ower, Alison K., et al.
Publicado: (2017)

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
por: Gerrits, Emma, et al.
Publicado: (2021)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
por: Cheng, Yuan, et al.
Publicado: (2022)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
por: Mashal, Yara, et al.
Publicado: (2022)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Galantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer's disease
por: Castillo, Willian O., et al.
Publicado: (2017)

Recent advancements toward non-invasive imaging of retinal amyloid-beta for early detection of Alzheimer’s disease
por: Wang, Liang, et al.
Publicado: (2022)

Beta‐amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease
por: Pannuzzo, Martina
Publicado: (2021)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8nbgkn13u3npq6qujnnafki2k2